FilingSEC EDGAR8-K
Lipocine Receives Health Canada Approval for TLANDO®
· SEC accepted
StageApproval
Filing content
Lipocine announced that its partner Verity Pharma received Health Canada approval for TLANDO® for testosterone replacement therapy in adult males, with a planned launch by the end of 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…